Fred Ginnebaugh

Investor at Raydiant Oximetry

Fred Ginnebaugh, MBA, is a seasoned executive with extensive experience in sales, marketing, and corporate strategy within the medical technology sector. Currently serving as the Sr. Director of Sales, Marketing, and Strategy at Earlens Corporation since October 2020, Fred also holds positions as an Executive in Residence at KCK Group and as an investor in several healthcare startups, including Raydiant Oximetry, Mindbloom, CivilGrid, and HealthPersonas. Prior experience includes roles such as Executive Client Director at GE Healthcare, where Fred succeeded in managing strategic relationships with major health systems, and Senior Cardiothoracic Territory Manager at Getinge North America. Fred's educational background includes an MBA from The Wharton School, an MS in Mechanical Engineering from the University of California, Berkeley, and a BS in Mechanical Engineering from the University of Michigan.

Location

San Francisco, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Raydiant Oximetry

Raydiant Oximetry is a company dedicated to the mission of keeping mothers and babies safe during childbirth. They are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood.


Industries

Employees

11-50

Links